Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis

Journal of Clinical Virology

Volumn 38, Issue 4, 2007, Pages 292-297

  Nystad, Tone Wikene ^a   Myrmel, Helge ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antibody; Diagnosis; EBV

Indexed keywords

EPSTEIN BARR NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG; VIRUS CAPSID ANTIGEN;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME IMMUNOASSAY; EPSTEIN BARR VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOCOMPETENCE; INFECTIOUS MONONUCLEOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; VIRUS INFECTION; VIRUS REACTIVATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, HETEROPHILE; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIGENS, VIRAL; CAPSID PROTEINS; CHILD; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFECTIOUS MONONUCLEOSIS; MIDDLE AGED; PREVALENCE; VIRUS ACTIVATION;

EID: 33947120283     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.01.006     Document Type: Article

References (13)

1. Aalto S.M., Linnavuori K., Peltola H., et al. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol 56 (1998) 186-191
2. Andersson A., Vetter V., Kreutzer L., et al. Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology. J Med Virol 43 (1994) 238-244
3. Bauer G. Simplicity through complexity: immunoblot with recombinant antigens as the new gold standard in Epstein-Barr virus serology. Clin Lab 47 (2001) 223-230
4. Blake J.J.M., Edwards J.J.M., Fletcher W.W., et al. Measurement of heterophil antibody and antibodies to EB viral capsid antigen IgG and IgM in suspected cases of infectious mononucleosis. J Clin Pathol 29 (1976) 841-847
5. Bruu A.L., Hjetland R., Holter E., et al. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol 7 (2000) 451-456
6. de Ory F., Antonaya J., Fernandez M.V., et al. Application of low-avidity immunoglobulin G studies to diagnosis of Epstein-Barr virus infectious mononucleosis. J Clin Microbiol 31 (1993) 1669-1671
7. Gartner B.C., Hess R.D., Bandt D., et al. Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method. Clin Diagn Lab Immunol 10 (2003) 78-82
8. Gray J.J. Avidity of EBV VCA-specific IgG antibodies: distinction between recent primary infection, past infection and reactivation. J Virol Methods 52 (1995) 95-104
9. Nalesnik M.A. Epstein-Barr Virus. In: Lennette E.H., and Smith T.F. (Eds). Laboratory diagnosis of viral infections (1999), Marcel Dekker, Inc., New York 385-419
10. Obel N., Hoier-Madsen M., and Kangro H. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection. Apmis 104 (1996) 424-428
11. Robertson P., Beynon S., Whybin R., et al. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection. J Med Virol 70 (2003) 617-623
12. Sumaya C.V. Endogenous reactivation of Epstein-Barr virus infections. J Infect Dis 135 (1977) 374-379
13. Sumaya C.V., and Ench Y. Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics 75 (1985) 1011-1019